MedPage Today on MSN
Achieving Cure in Multiple Myeloma
ASCO discussant Krina Patel, MD, of the University of Texas MD Anderson Cancer Center in Houston, noted, "Ciltacabtagene ...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today ...
Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...
AbbVie Inc. (NYSE: ABBV) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the possible change in ...
AbbVie (NYSE: ABBV) has outperformed the market over the past 5 years by 3.1% on an annualized basis producing an average annual return of 17.03%. Currently, AbbVie has a market capitalization of $383 ...
Zacks Investment Research on MSN
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback